MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer

Challenges in medical care posed by rapid tumor progression, individualized responses to therapy, and the heterogeneous characteristics of breast cancer (BRCA) highlight the urgent need for new treatment strategies, as well as therapeutic and prognostic markers. Accumulating evidence has revealed th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of translational medicine 2022-02, Vol.10 (4), p.203-203
Hauptverfasser:	Yang, Meng, Xiao, Ran, Wang, Xinru, Xiong, Youyi, Duan, Zhenfeng, Li, Duolu, Kan, Quancheng
Format:	Artikel
Sprache:	eng
Schlagworte:	Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!